|
|
||||||||
American Journal of Clinical Nutrition, Vol 56, 1061-1065, Copyright © 1992 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
K Landin, G Holm, L Tengborn and U Smith
Department of Medicine, Sahlgrenska Hospital, University of Goteborg, Sweden.
A double-blind, placebo-controlled, cross-over study was carried out in 25 healthy, nonobese middle-aged men to test the effect of guar gum on glucose and lipid metabolism, blood pressure, and fibrinolysis. Ten grams guar or placebo granulate was given three times a day for 6 wk with a 2-wk run-in before and a wash-out period after. Decreases in fasting blood glucose (P < 0.001), cholesterol (P < 0.001), triglycerides (P < 0.05), plasminogen activator inhibitor-1 activity (P < 0.01), systolic blood pressure (P < 0.01), and diastolic blood pressure (P < 0.001) were seen during guar treatment when compared with placebo. Insulin sensitivity, measured with the euglycemic-clamp technique, increased (P < 0.01), adipose tissue-glucose uptake measured in vitro increased (P < 0.001), and 24-h urinary excretion of sodium and potassium increased (P < 0.001) during guar treatment. Fasting plasma insulin, renin, aldosterone, and fibrinogen concentrations as well as skeletal-muscle electrolytes, urinary catecholamines, and body weight remained unaltered. These findings support a role for guar in the treatment of the metabolic syndrome in which insulin resistance seems to play a pivotal role.
This article has been cited by other articles:
![]() |
J. A. Renteria-Flores, L. J. Johnston, G. C. Shurson, R. L. Moser, and S. K. Webel Effect of soluble and insoluble dietary fiber on embryo survival and sow performance J Anim Sci, October 1, 2008; 86(10): 2576 - 2584. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Rideout, Z. Yuan, M. Bakovic, Q. Liu, R.-K. Li, Y. Mine, and M. Z. Fan Guar Gum Consumption Increases Hepatic Nuclear SREBP2 and LDL Receptor Expression in Pigs Fed an Atherogenic Diet J. Nutr., March 1, 2007; 137(3): 568 - 572. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Rizkalla, L. Taghrid, M. Laromiguiere, D. Huet, J. Boillot, A. Rigoir, F. Elgrably, and G. Slama Improved Plasma Glucose Control, Whole-Body Glucose Utilization, and Lipid Profile on a Low-Glycemic Index Diet in Type 2 Diabetic Men: A randomized controlled trial Diabetes Care, August 1, 2004; 27(8): 1866 - 1872. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-L. Chen, W. H.-H. Sheu, T.-S. Tai, Y.-P. Liaw, and Y.-C. Chen Konjac Supplement Alleviated Hypercholesterolemia and Hyperglycemia in Type 2 Diabetic Subjects--A Randomized Double-Blind Trial J. Am. Coll. Nutr., February 1, 2003; 22(1): 36 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. X Lu, K. Z Walker, J. G Muir, T. Mascara, and K. O'Dea Arabinoxylan fiber, a byproduct of wheat flour processing, reduces the postprandial glucose response in normoglycemic subjects Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1123 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Brown, B. Rosner, W. W Willett, and F. M Sacks Cholesterol-lowering effects of dietary fiber: a meta-analysis Am. J. Clinical Nutrition, January 1, 1999; 69(1): 30 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gori and R. K. Campbell Natural Products and Diabetes Treatment The Diabetes Educator, January 1, 1998; 24(2): 201 - 208. [PDF] |
||||
![]() |
D. Cameron-Smith, R. Habito, M. Barnett, and G. R. Collier Dietary Guar Gum Improves Insulin Sensitivity in Streptozotocin-Induced Diabetic Rats J. Nutr., February 1, 1997; 127(2): 359 - 364. [Abstract] [Full Text] |
||||
![]() |
T. A. Kotchen Attenuation of Hypertension by Insulin-Sensitizing Agents Hypertension, August 1, 1996; 28(2): 219 - 223. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |